Horizon Quantum Holdings Ltd. awarded Chief Product Officer Chew Qian Yi Amanda 17,857 derivative securities on Aug. 17, 2026, leaving her with 17,857 derivative securities. The disclosed award equals 100.0% of her resulting derivative-securities holding, giving investors the stated ownership outcome of the transaction.
Key Highlights
- The award was recorded on Aug. 17, 2026, under transaction code A.
- Chew Qian Yi Amanda serves as Chief Product Officer of Horizon Quantum Holdings Ltd.
- Her post-transaction derivative-securities holding was 17,857.
Horizon Quantum Holdings Ltd. (NASDAQ: HQ) awarded Chief Product Officer Chew Qian Yi Amanda 17,857 derivative securities on Aug. 17, 2026. The award represented 100.0% of her resulting derivative-securities holding, with the post-transaction holding recorded at 17,857 derivative securities.
Award Creates Full Disclosed Derivative Holding
The disclosed 100.0% figure describes the award’s share of Chew’s resulting derivative-securities holding in Horizon Quantum Holdings Ltd.
FAQs
Q: What insider transaction did Horizon Quantum Holdings report?
A: Horizon Quantum Holdings awarded Chief Product Officer Chew Qian Yi Amanda 17,857 derivative securities. The transaction took place on Aug. 17, 2026.
Q: How many derivative securities did Chew Qian Yi Amanda own afterward?
A: Chew Qian Yi Amanda’s resulting holding was 17,857 derivative securities. The disclosed award represented 100.0% of that resulting derivative-securities holding.
Q: What does transaction code A mean in this case?
A: Transaction code A identifies an award or grant. Horizon Quantum Holdings used that classification for the 17,857 derivative securities awarded to Chew.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.